398 results on '"Mielke, S."'
Search Results
2. World Supply, Demand and Competition for Soybeans and Products in the Eighties and Nineties
3. Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation—a retrospective analysis on seven patients
4. TRANSCEND FL: PHASE 2 STUDY RESULTS OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
5. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS
6. Transcription-driven twin supercoiling of a DNA loop: A Brownian dynamics study
7. Dynamics of the Simplest Chlorine Atom Reaction: An Experimental and Theoretical Study
8. P092 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS
9. Detection of T-cell immune responses against cytomegalovirus in seronegative healthy blood donors: a potential source for adoptive immune transfer [Abstract]
10. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
11. S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B
12. S238: MATCHED RELATED VERSUS UNRELATED VERSUS HAPLOIDENTICAL DONORS FOR ALLOGENEIC TRANSPLANTATION IN AML PATIENTS ACHIEVING FIRST COMPLETE REMISSION AFTER TWO INDUCTION COURSES: A STUDY FROM THE ALWP/EBMT
13. Management of adults and children receiving CAR T- cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
14. Salvage therapy with everolimus reduces the severity of treatment-refractory chronic GVHD without impairing disease control: A dual center retrospective analysis
15. Die photochemische Bildung des Chlorwasserstoffs Dynamics of Cl + H2 ⇌ HC1 + H on a New Potential Energy Surface: The Photosynthesis of Hydrogen Chloride Revisited 100 Years after Max Bodenstein
16. High prevalence of distress in patients after allogeneic hematopoietic SCT: Fear of progression is associated with a younger age
17. EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT
18. Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT
19. Immunotherapy for viral and fungal infections
20. Role of allo-SCT for CML in 2010
21. Management of relapse after allo-SCT for AML and the role of second transplantation
22. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia
23. Estimation of protein secondary structure content directly from NMR spectra using an improved empirical correlation with averaged chemical shift
24. Stem-like characteristics in a subset of CD161-expressing human memory CD4+ T-cells may facilitate their survival after chemotherapy: O184
25. Procédures opérationnelles standards (POS)
26. The in vitro diffusion of several antimicrobial otic preparations through canine cerumen: P-099
27. Allogeneic blood stem cell transplantation form alternative stem cell sources: Cord blood or haploidentical donor or adult unrelated mismatched donor: V622
28. Retrospective analysis of clofarabine/Ara-C salvage chemotherapy preceding allogeneic stem cell transplantation for AML: P935
29. Efficiency of Photosynthesis in a Chl d-Utilizing Cyanobacterium is Comparable to or Higher than that in Chl a-Utilizing Oxygenic Species
30. Separation of GvHD and GvL by depleting GvHD-mediating T cells: V611
31. Creep Behavior of Mg-Alloys AE42 and AZ91 Reinforced with Carbon Short Fibers
32. Selective depletion strategies in allogeneic stem cell transplantation
33. Variants in the SLCO1B3 Gene: Interethnic Distribution and Association with Paclitaxel Pharmacokinetics
34. Evolution of the Vacuum Rabi Splitting Into a Single Peak for a Bistable Optical Cavity
35. Protein structural class identification directly from NMR spectra using averaged chemical shifts*
36. Comparison of 1-Hour and 3-Hours Paclitaxel Infusion Pharmacokinetics: Results from a Randomized Trial
37. Die photochemische Bildung des Chlorwasserstoffs Dynamics of Cl + H2 ⇌ HC1 + H on a New Potential Energy Surface: The Photosynthesis of Hydrogen Chloride Revisited 100 Years after Max Bodenstein
38. CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL-TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
39. PF767 PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF ONE OR TWO DOSES OF DONOR LYMPHOCYTES DEPLETED OF HOST ALLOREACTIVE T-CELLS (ATIR101) FOLLOWING T-CELL-DEPLETED HAPLOIDENTICAL HSCT
40. INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL
41. A single dose of donor lymphocytes depleted of anti-host reactive T cells (ATIR101) following T-cell-depleted haploidentical HSCT is safe and efficaceous
42. Hypermirroring- a novel empathy disorder or a gift?
43. Etablierung und Aktivierung von Sphäroiden hepatischer und pankreatischer Sternzellen
44. Phase II study of haploidentical stem cell transplantation using ex vivo photodepletion of donor lymphocyte infusions to eliminate anti-host reactivity results in low relapse rates and high survival rates: Final 2 year follow-up
45. Keramische Fasern für wasserfeste Leichtmetalle
46. GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)-AN INTERIM ANALYSIS
47. Hydroa Vacciniforme-like Skin Lesions in Epstein-Barr-Virus-associated T-cell Lymphoproliferation with Subsequent Development of Aggressive NK/T-cell Lymphoma
48. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: An observational cohort study
49. Phase II Clinical Trial of Allodepleted T Cell Immunotherapy (ATIR101) Post-Transplant Results in Decreased Transplant-Related Mortality and Improved Survival in Acute Leukemia Patients Undergoing T-Depleted Haploidentical Stem Cell Transplantation
50. 98 The cystic fibrosis lower airways microbial metagenome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.